ZCM
BMY icon

Ziegler Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Ziegler Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$3.05M Sell
56,677
-101,671
-64% -$5.18M 0.12% 188
2023
Q4 		$8.13M Sell
158,348
-19,731
-11% -$1.04M 0.37% 63
2023
Q3 		$10.3M Sell
178,079
-19,905
-10% -$1.22M 0.41% 78
2023
Q2 		$12.7M Sell
197,984
-5,153
-3% -$346K 0.48% 50
2023
Q1 		$14.1M Sell
203,137
-1,770
-0.9% -$125K 0.56% 38
2022
Q4 		$14.7M Sell
204,907
-2,009
-1% -$151K 0.62% 30
2022
Q3 		$14.7M Sell
206,916
-7,215
-3% -$523K 0.65% 27
2022
Q2 		$16.5M Sell
214,131
-2,411
-1% -$184K 0.68% 25
2022
Q1 		$15.9M Sell
216,542
-121,578
-36% -$8.16M 0.67% 29
2021
Q4 		$21.1M Sell
338,120
-4,584
-1% -$269K 0.76% 18
2021
Q3 		$20.3M Sell
342,704
-20,268
-6% -$1.33M 0.73% 20
2021
Q2 		$24.3M Buy
362,972
+19,630
+6% +$1.28M 0.81% 15
2021
Q1 		$21.7M Buy
343,342
+129,349
+60% +$8.05M 0.68% 31
2020
Q4 		$13.3M Sell
213,993
-60,667
-22% -$3.73M 0.44% 73
2020
Q3 		$16.6M Buy
274,660
+12,379
+5% +$745K 0.64% 34
2020
Q2 		$15.4M Sell
262,281
-45,548
-15% -$2.72M 0.49% 50
2020
Q1 		$17.2M Buy
+307,829
New +$18.8M 0.46% 54
2013
Q3 		$3.03M Sell
65,394
-76,829
-54% -$3.37M 0.26% 111
2013
Q2 		$6.36M Buy
+142,223
New +$6.17M 0.68% 32

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ziegler Capital Management's BMY Position: Q1 2024 in Review

Ziegler Capital Management reduced its Bristol-Myers Squibb (BMY) stake by 64% in Q1 2024, selling an estimated $5.18M and leaving 56,677 shares worth $3.05M. The position accounts for 0.12% of the portfolio, ranked #188.

Ziegler Capital Management first reported a position in BMY in Q2 2013 and has held it in 19 quarters since. The position peaked at $24.3M in Q2 2021. 2,332 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

  • Ziegler Capital Management held 56,677 shares of Bristol-Myers Squibb worth $3.05M as of Q1 2024.
  • Ziegler Capital Management sold 101,671 Bristol-Myers Squibb shares in Q1 2024, an estimated $5.18M.
  • Bristol-Myers Squibb made up 0.12% of Ziegler Capital Management's portfolio in Q1 2024, its #188 holding.
  • Ziegler Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 19 quarters since.
  • Ziegler Capital Management's Bristol-Myers Squibb position peaked at $24.3M in Q2 2021.
  • 2,332 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on Ziegler Capital Management's 13F filing for Q1 2024, filed 15 May 2024.